Charles Albright is the founder of Affinia Therapeutics. Affinia Therapeutics has raised $210M in total funding. Latest round: Series B. Based in Waltham, MA.
Charles F. Albright is the Chief Scientific Officer (CSO) at Affinia Therapeutics, a gene therapy company. He joined Affinia in January 2021 and previously held roles at Editas Medicine and Novartis. Albright also serves on the Scientific Advisory Board of NanoCell Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library